Comparison of Activity and Safety of DSPAα1 and Its N-Glycosylation Mutants

DSPAα1 is a potent rude thrombolytic protein with high medicative value. DSPAα1 has two natural N-glycan sites (N153Q-S154-S155, N398Q-K399-T400) that may lead to immune responses when administered in vivo. We aimed to study the effect of its N-glycosylation sites on DSPAα1 in vitro and in vivo by m...

Full description

Saved in:
Bibliographic Details
Published inLife (Basel, Switzerland) Vol. 13; no. 4; p. 985
Main Authors Peng, Huakang, Wang, Nan, Wang, Mengqi, Yang, Caifeng, Guo, Wenfang, Li, Gangqiang, Huang, Sumei, Wei, Di, Liu, Dehu
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 01.04.2023
MDPI
Subjects
Amino acids
Bleeding
Cloning
Coagulation
Comparative analysis
Coronaviruses
COVID-19
Development and progression
drug safety
Drug therapy
DSPAα1
E coli
Fibrin
fibrin selectivity
Genetic aspects
Glycan
Glycoproteins
Glycosylation
Health aspects
Immune response
Immunological tolerance
In vivo methods and tests
Mutagenesis
Mutants
Mutation
N-glycosylation sites
Pharmaceuticals
Physiological aspects
Physiological effects
Plasmids
plasminogen activator
Proteins
rat
Safety
Temperature tolerance
Testing
Thromboembolism
Thrombolysis
Thrombolytic drugs
Yeast
China
Beijing China
United States > US
DSPAα1
plasminogen activator
N-glycosylation sites
fibrin selectivity
rat
drug safety
Online AccessGet full text

Cover

Abstract DSPAα1 is a potent rude thrombolytic protein with high medicative value. DSPAα1 has two natural N-glycan sites (N153Q-S154-S155, N398Q-K399-T400) that may lead to immune responses when administered in vivo. We aimed to study the effect of its N-glycosylation sites on DSPAα1 in vitro and in vivo by mutating these N-glycosylation sites. In this experiment, four single mutants and one double mutant were predicted and expressed in Pichia pastoris. When the N398Q-K399-T400 site was mutated, the fibrinolytic activity of the mutant was reduced by 75%. When the N153Q-S154-S155 sites were inactivated as described above, the plasminogen activating activity of its mutant was reduced by 40%, and fibrin selectivity was significantly reduced by 21-fold. The introduction of N-glycosylation on N184-G185-A186T and K368N-S369-S370 also considerably reduced the activity and fibrin selectivity of DSPAα1. The pH tolerance and thermotolerance of all mutants did not change significantly. In vivo experiments also confirmed that N-glycosylation mutations can reduce the safety of DSPAα1, lead to prolonged bleeding time, non-physiological reduction of coagulation factor (α2-AP, PAI) concentration, and increase the risk of irregular bleeding. This study ultimately demonstrated the effect of N-glycosylation mutations on the activity and safety of DSPAα1.
AbstractList DSPAα1 is a potent rude thrombolytic protein with high medicative value. DSPAα1 has two natural N-glycan sites (N153Q-S154-S155, N398Q-K399-T400) that may lead to immune responses when administered in vivo. We aimed to study the effect of its N-glycosylation sites on DSPAα1 in vitro and in vivo by mutating these N-glycosylation sites. In this experiment, four single mutants and one double mutant were predicted and expressed in . When the N398Q-K399-T400 site was mutated, the fibrinolytic activity of the mutant was reduced by 75%. When the N153Q-S154-S155 sites were inactivated as described above, the plasminogen activating activity of its mutant was reduced by 40%, and fibrin selectivity was significantly reduced by 21-fold. The introduction of N-glycosylation on N184-G185-A186T and K368N-S369-S370 also considerably reduced the activity and fibrin selectivity of DSPAα1. The pH tolerance and thermotolerance of all mutants did not change significantly. In vivo experiments also confirmed that N-glycosylation mutations can reduce the safety of DSPAα1, lead to prolonged bleeding time, non-physiological reduction of coagulation factor (α2-AP, PAI) concentration, and increase the risk of irregular bleeding. This study ultimately demonstrated the effect of N-glycosylation mutations on the activity and safety of DSPAα1.
DSPAα1 is a potent rude thrombolytic protein with high medicative value. DSPAα1 has two natural N-glycan sites (N153Q-S154-S155, N398Q-K399-T400) that may lead to immune responses when administered in vivo. We aimed to study the effect of its N-glycosylation sites on DSPAα1 in vitro and in vivo by mutating these N-glycosylation sites. In this experiment, four single mutants and one double mutant were predicted and expressed in Pichia pastoris. When the N398Q-K399-T400 site was mutated, the fibrinolytic activity of the mutant was reduced by 75%. When the N153Q-S154-S155 sites were inactivated as described above, the plasminogen activating activity of its mutant was reduced by 40%, and fibrin selectivity was significantly reduced by 21-fold. The introduction of N-glycosylation on N184-G185-A186T and K368N-S369-S370 also considerably reduced the activity and fibrin selectivity of DSPAα1. The pH tolerance and thermotolerance of all mutants did not change significantly. In vivo experiments also confirmed that N-glycosylation mutations can reduce the safety of DSPAα1, lead to prolonged bleeding time, non-physiological reduction of coagulation factor (α2-AP, PAI) concentration, and increase the risk of irregular bleeding. This study ultimately demonstrated the effect of N-glycosylation mutations on the activity and safety of DSPAα1.
DSPAα1 is a potent rude thrombolytic protein with high medicative value. DSPAα1 has two natural N-glycan sites (N153Q-S154-S155, N398Q-K399-T400) that may lead to immune responses when administered in vivo. We aimed to study the effect of its N-glycosylation sites on DSPAα1 in vitro and in vivo by mutating these N-glycosylation sites. In this experiment, four single mutants and one double mutant were predicted and expressed in Pichia pastoris . When the N398Q-K399-T400 site was mutated, the fibrinolytic activity of the mutant was reduced by 75%. When the N153Q-S154-S155 sites were inactivated as described above, the plasminogen activating activity of its mutant was reduced by 40%, and fibrin selectivity was significantly reduced by 21-fold. The introduction of N-glycosylation on N184-G185-A186T and K368N-S369-S370 also considerably reduced the activity and fibrin selectivity of DSPAα1. The pH tolerance and thermotolerance of all mutants did not change significantly. In vivo experiments also confirmed that N-glycosylation mutations can reduce the safety of DSPAα1, lead to prolonged bleeding time, non-physiological reduction of coagulation factor (α2-AP, PAI) concentration, and increase the risk of irregular bleeding. This study ultimately demonstrated the effect of N-glycosylation mutations on the activity and safety of DSPAα1.
DSPAα1 is a potent rude thrombolytic protein with high medicative value. DSPAα1 has two natural N-glycan sites (N153Q-S154-S155, N398Q-K399-T400) that may lead to immune responses when administered in vivo. We aimed to study the effect of its N-glycosylation sites on DSPAα1 in vitro and in vivo by mutating these N-glycosylation sites. In this experiment, four single mutants and one double mutant were predicted and expressed in Pichia pastoris. When the N398Q-K399-T400 site was mutated, the fibrinolytic activity of the mutant was reduced by 75%. When the N153Q-S154-S155 sites were inactivated as described above, the plasminogen activating activity of its mutant was reduced by 40%, and fibrin selectivity was significantly reduced by 21-fold. The introduction of N-glycosylation on N184-G185-A186T and K368N-S369-S370 also considerably reduced the activity and fibrin selectivity of DSPAα1. The pH tolerance and thermotolerance of all mutants did not change significantly. In vivo experiments also confirmed that N-glycosylation mutations can reduce the safety of DSPAα1, lead to prolonged bleeding time, non-physiological reduction of coagulation factor (α2-AP, PAI) concentration, and increase the risk of irregular bleeding. This study ultimately demonstrated the effect of N-glycosylation mutations on the activity and safety of DSPAα1.DSPAα1 is a potent rude thrombolytic protein with high medicative value. DSPAα1 has two natural N-glycan sites (N153Q-S154-S155, N398Q-K399-T400) that may lead to immune responses when administered in vivo. We aimed to study the effect of its N-glycosylation sites on DSPAα1 in vitro and in vivo by mutating these N-glycosylation sites. In this experiment, four single mutants and one double mutant were predicted and expressed in Pichia pastoris. When the N398Q-K399-T400 site was mutated, the fibrinolytic activity of the mutant was reduced by 75%. When the N153Q-S154-S155 sites were inactivated as described above, the plasminogen activating activity of its mutant was reduced by 40%, and fibrin selectivity was significantly reduced by 21-fold. The introduction of N-glycosylation on N184-G185-A186T and K368N-S369-S370 also considerably reduced the activity and fibrin selectivity of DSPAα1. The pH tolerance and thermotolerance of all mutants did not change significantly. In vivo experiments also confirmed that N-glycosylation mutations can reduce the safety of DSPAα1, lead to prolonged bleeding time, non-physiological reduction of coagulation factor (α2-AP, PAI) concentration, and increase the risk of irregular bleeding. This study ultimately demonstrated the effect of N-glycosylation mutations on the activity and safety of DSPAα1.
Audience Academic
Author Wang, Mengqi
Peng, Huakang
Wang, Nan
Liu, Dehu
Wei, Di
Yang, Caifeng
Li, Gangqiang
Huang, Sumei
Guo, Wenfang
AuthorAffiliation 2 Biotechnology Research Institute, Guangxi Academy of Agricultural Sciences, Nanning 530007, China
1 Biotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China
AuthorAffiliation_xml – name: 2 Biotechnology Research Institute, Guangxi Academy of Agricultural Sciences, Nanning 530007, China
– name: 1 Biotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China
Author_xml – sequence: 1
  givenname: Huakang
  orcidid: 0000-0003-3991-9375
  surname: Peng
  fullname: Peng, Huakang
– sequence: 2
  givenname: Nan
  surname: Wang
  fullname: Wang, Nan
– sequence: 3
  givenname: Mengqi
  surname: Wang
  fullname: Wang, Mengqi
– sequence: 4
  givenname: Caifeng
  surname: Yang
  fullname: Yang, Caifeng
– sequence: 5
  givenname: Wenfang
  surname: Guo
  fullname: Guo, Wenfang
– sequence: 6
  givenname: Gangqiang
  surname: Li
  fullname: Li, Gangqiang
– sequence: 7
  givenname: Sumei
  surname: Huang
  fullname: Huang, Sumei
– sequence: 8
  givenname: Di
  surname: Wei
  fullname: Wei, Di
– sequence: 9
  givenname: Dehu
  surname: Liu
  fullname: Liu, Dehu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37109514$$D View this record in MEDLINE/PubMed
BookMark eNptkstuEzEUhi1UREvojjUaiQ1ITPF9PCsUhVIihYsIrC2PL8HRZBzGnqp5LF6EZ8JpSskg7IWPfn_nt318HoOTLnQWgKcIXhBSw9etdxYRSGEt2ANwhmHFSlTh-uQoPgXnMa5hHpwhLugjcEoqBGuG6BlYzMJmq3ofQ1cEV0x18tc-7QrVmWKpnM1hlt8uP09__US36jzF4mN51e50iLtWJZ8zPwxJdSk-AQ-daqM9v1sn4Nu7y6-z9-Xi09V8Nl2UmpEqlQohp0wDhYG8IaQSnDLFVI0rC6k2uLbaUIWFNbpBBjtOHK6IgZgLC0n2mID5wdcEtZbb3m9Uv5NBeXkrhH4lVZ-8bq1kDFrFnG5sTWltsOBWoMowVzsOCUbZ683Bazs0m3yi7VKv2pHpeKfz3-UqXEsEEWU4X2wCXtw59OHHYGOSGx-1bVvV2TBEiQWsakQ5ghl9_g-6DkPf5VrtKc4YFpj_pVYqv8B3LuSD9d5UTisGCYX59zJ18R8qT2M3Xuc2cT7ro4SXo4TMJHuTVmqIUc6XX8bss-Oq3JfjT-Nk4NUB0H2IsbfuHkFQ7ltTHrcm-Q3wVtI3
Cites_doi 10.1182/blood-2013-08-517474
10.1182/blood-2007-11-123885
10.1373/clinchem.2015.238394
10.1161/01.CIR.91.5.1540
10.1159/000342900
10.1002/biot.200700214
10.1038/nature13083
10.2174/1871527315666161213110104
10.3389/fpls.2016.02052
10.1016/j.jacc.2020.08.041
10.1016/S0021-9258(19)37103-0
10.1007/s11248-021-00292-5
10.1021/jacs.9b05365
10.1002/(SICI)1097-0061(199605)12:6<541::AID-YEA935>3.0.CO;2-A
10.1161/01.STR.0000049764.49162.76
10.1016/0378-1119(91)90155-5
10.1006/meth.2001.1262
10.1093/glycob/7.1.67
10.1021/acs.est.8b03180
10.1016/0003-2697(76)90527-3
10.1093/nar/gks512
10.1161/CIRCULATIONAHA.109.887513
10.1111/j.2042-7158.2012.01457.x
10.1161/CIRCRESAHA.111.247684
10.1111/jth.14872
10.1002/jps.20319
10.1128/AEM.02619-14
10.1016/0378-1119(92)90526-U
10.1038/nature13288
10.1016/j.neuron.2019.08.042
10.1105/tpc.106.045948
10.1182/blood.V76.12.2560.2560
10.1021/jo050278f
10.1186/s12915-015-0136-2
10.1006/abbi.1999.1115
10.1007/s00134-013-2822-2
10.1038/s41418-018-0115-6
10.1016/j.jconrel.2011.09.069
10.1186/1477-9560-4-14
10.1161/CIRCRESAHA.111.255398
10.1016/j.biomaterials.2007.04.026
10.1021/bi971129x
10.1161/01.CIR.84.1.244
10.1182/blood-2016-09-742999
10.1126/science.aar5140
10.1038/nprot.2008.213
10.1016/S0021-9258(19)84664-1
10.1016/S0268-9499(08)80020-3
10.1182/blood.2019000049
10.1016/0168-1656(94)00146-4
10.3390/cimb44090270
10.1172/JCI65853
10.1074/jbc.270.43.25596
10.2174/187152708784936608
10.1161/CIRCULATIONAHA.110.000885
10.1021/ja106896t
ContentType Journal Article
Copyright COPYRIGHT 2023 MDPI AG
2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2023 by the authors. 2023
Copyright_xml – notice: COPYRIGHT 2023 MDPI AG
– notice: 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2023 by the authors. 2023
DBID AAYXX
CITATION
NPM
ISR
8FD
8FE
8FH
ABUWG
AEUYN
AFKRA
ATCPS
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
COVID
DWQXO
FR3
GNUQQ
HCIFZ
LK8
M7P
P64
PATMY
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.3390/life13040985
DatabaseName CrossRef
PubMed
Gale In Context: Science
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
Coronavirus Research Database
ProQuest Central
Engineering Research Database
ProQuest Central Student
ProQuest SciTech Premium Collection
Biological Sciences
Biological Science Database
Biotechnology and BioEngineering Abstracts
Environmental Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Genetics Abstracts
Natural Science Collection
ProQuest Central Korea
Agricultural & Environmental Science Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Coronavirus Research Database
Biological Science Database
ProQuest SciTech Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
ProQuest One Academic UKI Edition
Environmental Science Database
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
MEDLINE - Academic
DatabaseTitleList PubMed
Publicly Available Content Database


MEDLINE - Academic

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2075-1729
ExternalDocumentID oai_doaj_org_article_550ea5fcbe9449d286e817d5f9f60321
PMC10145227
A750340109
37109514
10_3390_life13040985
Genre Journal Article
GeographicLocations China
Beijing China
United States--US
GeographicLocations_xml – name: China
– name: Beijing China
– name: United States--US
GrantInformation_xml – fundername: Foundation of Hainan Yazhou Bay Seed Lab
  grantid: B21HJ0212
– fundername: National Natural Science Foundation of China
  grantid: 31901661
GroupedDBID 53G
5VS
7XC
8FE
8FH
AADQD
AAFWJ
AAYXX
ABDBF
ACUHS
ADBBV
AEUYN
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
CCPQU
CITATION
DIK
ESX
GROUPED_DOAJ
HCIFZ
HYE
IAO
IEP
ISR
ITC
KQ8
LK8
M48
M7P
MODMG
M~E
OK1
PATMY
PGMZT
PHGZM
PHGZT
PIMPY
PROAC
PYCSY
RPM
NPM
PMFND
8FD
ABUWG
AZQEC
COVID
DWQXO
FR3
GNUQQ
P64
PKEHL
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
RC3
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c537t-a11fadb08d06b3378645a5a927e04cd29ecd4a28edcb1d2f63f273d0268e03c53
IEDL.DBID M48
ISSN 2075-1729
IngestDate Wed Aug 27 01:27:20 EDT 2025
Thu Aug 21 18:38:04 EDT 2025
Fri Jul 11 11:34:24 EDT 2025
Fri Jul 25 11:58:38 EDT 2025
Tue Jun 17 22:11:38 EDT 2025
Tue Jun 10 21:08:14 EDT 2025
Fri Jun 27 06:00:04 EDT 2025
Wed Feb 19 02:24:46 EST 2025
Tue Jul 01 02:59:55 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords DSPAα1
plasminogen activator
N-glycosylation sites
fibrin selectivity
rat
drug safety
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c537t-a11fadb08d06b3378645a5a927e04cd29ecd4a28edcb1d2f63f273d0268e03c53
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally to this work.
ORCID 0000-0003-3991-9375
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/life13040985
PMID 37109514
PQID 2806552826
PQPubID 2032373
ParticipantIDs doaj_primary_oai_doaj_org_article_550ea5fcbe9449d286e817d5f9f60321
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10145227
proquest_miscellaneous_2807914610
proquest_journals_2806552826
gale_infotracmisc_A750340109
gale_infotracacademiconefile_A750340109
gale_incontextgauss_ISR_A750340109
pubmed_primary_37109514
crossref_primary_10_3390_life13040985
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-04-01
PublicationDateYYYYMMDD 2023-04-01
PublicationDate_xml – month: 04
  year: 2023
  text: 2023-04-01
  day: 01
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Life (Basel, Switzerland)
PublicationTitleAlternate Life (Basel)
PublicationYear 2023
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Jacobs (ref_63) 2009; 4
Elmaraezy (ref_10) 2017; 16
Gardell (ref_16) 1990; 76
Michaelis (ref_40) 1913; 49
Gohlke (ref_34) 1997; 7
Han (ref_28) 1999; 364
Debens (ref_8) 2004; 6
Tekin (ref_45) 2013; 123
Renatus (ref_35) 1997; 36
Morant (ref_62) 2007; 19
Price (ref_61) 2010; 132
Prasad (ref_39) 2006; 4
Gardell (ref_14) 1989; 264
Krauss (ref_44) 2012; 40
Bradford (ref_38) 1976; 72
ref_22
Peng (ref_29) 2022; 44
Whyte (ref_2) 2020; 18
Wong (ref_24) 2005; 70
Singh (ref_59) 2019; 134
Bogousslavsky (ref_20) 2013; 69
Payne (ref_53) 2017; 129
Yan (ref_42) 2018; 20
ref_26
Boleij (ref_49) 2018; 52
Petri (ref_31) 1995; 39
Dingermann (ref_25) 2008; 3
Flemmig (ref_5) 2012; 64
Livak (ref_37) 2001; 25
Boulaftali (ref_51) 2011; 123
Kahler (ref_54) 2015; 61
Carey (ref_7) 2012; 110
ref_36
Haendler (ref_11) 1991; 105
Sinclair (ref_23) 2005; 94
Mellott (ref_19) 1992; 12
Yamakawa (ref_55) 2013; 39
Adibhatla (ref_17) 2008; 7
Tsujikawa (ref_48) 1996; 12
Bringmann (ref_12) 1995; 270
Wild (ref_21) 2018; 359
Hvidtfeldt (ref_60) 2010; 121
Zhang (ref_4) 2014; 509
Larsen (ref_56) 2007; 28
Levine (ref_50) 2019; 141
ref_46
Zhang (ref_33) 2022; 31
Fang (ref_47) 2018; 25
Ma (ref_6) 2013; 122
Beyene (ref_52) 2017; 7
Liu (ref_32) 2009; 25
Elsadek (ref_64) 2012; 157
Gulba (ref_9) 1995; 9
Zhang (ref_3) 2014; 509
Wolf (ref_57) 2011; 109
Liberatore (ref_13) 2003; 34
Montoney (ref_18) 1995; 91
Gardell (ref_43) 1991; 84
Nadkarni (ref_1) 2020; 76
French (ref_58) 2008; 111
Bergum (ref_15) 1992; 267
Jiang (ref_27) 2015; 81
Haendler (ref_30) 1992; 116
Kanda (ref_41) 2019; 104
References_xml – volume: 20
  start-page: 597
  year: 2018
  ident: ref_42
  article-title: Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells
  publication-title: Nature
– volume: 122
  start-page: 4094
  year: 2013
  ident: ref_6
  article-title: Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat (Desmodus rotundus) inhibits inflammation and thrombosis in vivo
  publication-title: Blood
  doi: 10.1182/blood-2013-08-517474
– volume: 111
  start-page: 4496
  year: 2008
  ident: ref_58
  article-title: A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: A report from the Children’s Oncology Group
  publication-title: Blood
  doi: 10.1182/blood-2007-11-123885
– volume: 61
  start-page: 776
  year: 2015
  ident: ref_54
  article-title: Standardizing the D-dimer Assay: Proposing the d-dimer International Managed Ratio
  publication-title: Clin. Chem.
  doi: 10.1373/clinchem.2015.238394
– volume: 91
  start-page: 1540
  year: 1995
  ident: ref_18
  article-title: Comparison of the bleeding potential of vampire bat salivary plasminogen activator versus tissue plasminogen activator in an experimental rabbit model
  publication-title: Circulation
  doi: 10.1161/01.CIR.91.5.1540
– volume: 69
  start-page: 108
  year: 2013
  ident: ref_20
  article-title: Stroke and patent foramen ovale in young individuals
  publication-title: Eur. Neurol.
  doi: 10.1159/000342900
– volume: 3
  start-page: 90
  year: 2008
  ident: ref_25
  article-title: Recombinant therapeutic proteins: Production platforms and challenges
  publication-title: Biotechnol. J.
  doi: 10.1002/biot.200700214
– volume: 509
  start-page: 115
  year: 2014
  ident: ref_3
  article-title: Structure of the human P2Y12 receptor in complex with an antithrombotic drug
  publication-title: Nature
  doi: 10.1038/nature13083
– volume: 16
  start-page: 789
  year: 2017
  ident: ref_10
  article-title: Desmoteplase for Acute Ischemic Stroke: A Systematic Review and Metaanalysis of Randomized Controlled Trials
  publication-title: CNS Neurol. Disord. Drug Targets
  doi: 10.2174/1871527315666161213110104
– volume: 7
  start-page: 2052
  year: 2017
  ident: ref_52
  article-title: A Virus-Derived Stacked RNAi Construct Confers Robust Resistance to Cassava Brown Streak Disease
  publication-title: Front. Plant Sci.
  doi: 10.3389/fpls.2016.02052
– volume: 76
  start-page: 1815
  year: 2020
  ident: ref_1
  article-title: Anticoagulation, Bleeding, Mortality, and Pathology in Hospitalized Patients with COVID-19
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/j.jacc.2020.08.041
– volume: 267
  start-page: 17726
  year: 1992
  ident: ref_15
  article-title: Vampire bat salivary plasminogen activator exhibits a strict and fastidious requirement for polymeric fibrin as its cofactor, unlike human tissue-type plasminogen activator. A kinetic analysis
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)37103-0
– volume: 31
  start-page: 149
  year: 2022
  ident: ref_33
  article-title: Identification, purification, and pharmacological activity analysis of Desmodus rotundus salivary plasminogen activator alpha1 (DSPAα1) expressed in transgenic rabbit mammary glands
  publication-title: Transgenic Res.
  doi: 10.1007/s11248-021-00292-5
– volume: 141
  start-page: 14210
  year: 2019
  ident: ref_50
  article-title: O-GlcNAc Engineering of GPCR Peptide-Agonists Improves Their Stability and in Vivo Activity
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/jacs.9b05365
– volume: 12
  start-page: 541
  year: 1996
  ident: ref_48
  article-title: Secretion of a variant of human single-chain urokinase-type plasminogen activator without an N-glycosylation site in the methylotrophic yeast, Pichia pastoris and characterization of the secreted product
  publication-title: Yeast
  doi: 10.1002/(SICI)1097-0061(199605)12:6<541::AID-YEA935>3.0.CO;2-A
– volume: 34
  start-page: 537
  year: 2003
  ident: ref_13
  article-title: Vampire bat salivary plasminogen activator (desmoteplase): A unique fibrinolytic enzyme that does not promote neurodegeneration
  publication-title: Stroke
  doi: 10.1161/01.STR.0000049764.49162.76
– volume: 105
  start-page: 229
  year: 1991
  ident: ref_11
  article-title: The plasminogen activator family from the salivary gland of the vampire bat Desmodus rotundus: Cloning and expression
  publication-title: Gene
  doi: 10.1016/0378-1119(91)90155-5
– volume: 25
  start-page: 402
  year: 2001
  ident: ref_37
  article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method
  publication-title: Methods
  doi: 10.1006/meth.2001.1262
– volume: 7
  start-page: 67
  year: 1997
  ident: ref_34
  article-title: Analysis of site-specific N-glycosylation of recombinant Desmodus rotundus salivary plasminogen activator rDSPA alpha 1 expressed in Chinese hamster ovary cells
  publication-title: Glycobiology
  doi: 10.1093/glycob/7.1.67
– volume: 52
  start-page: 13127
  year: 2018
  ident: ref_49
  article-title: Identification of Glycoproteins Isolated from Extracellular Polymeric Substances of Full-Scale Anammox Granular Sludge
  publication-title: Environ. Sci. Technol.
  doi: 10.1021/acs.est.8b03180
– volume: 72
  start-page: 248
  year: 1976
  ident: ref_38
  article-title: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  publication-title: Anal. Biochem.
  doi: 10.1016/0003-2697(76)90527-3
– volume: 40
  start-page: 8119
  year: 2012
  ident: ref_44
  article-title: High-resolution structures of two complexes between thrombin and thrombin-binding aptamer shed light on the role of cations in the aptamer inhibitory activity
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gks512
– volume: 121
  start-page: 1589
  year: 2010
  ident: ref_60
  article-title: Alcohol intake and risk of coronary heart disease in younger, middle-aged, and older adults
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.109.887513
– volume: 64
  start-page: 1025
  year: 2012
  ident: ref_5
  article-title: Serine-proteases as plasminogen activators in terms of fibrinolysis
  publication-title: J. Pharm. Pharmacol.
  doi: 10.1111/j.2042-7158.2012.01457.x
– volume: 109
  start-page: 1269
  year: 2011
  ident: ref_57
  article-title: Binding of CD40L to Mac-1’s I-domain involves the EQLKKSKTL motif and mediates leukocyte recruitment and atherosclerosis—But does not affect immunity and thrombosis in mice
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.111.247684
– volume: 18
  start-page: 1548
  year: 2020
  ident: ref_2
  article-title: Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19
  publication-title: J. Thromb. Haemost.
  doi: 10.1111/jth.14872
– volume: 94
  start-page: 1626
  year: 2005
  ident: ref_23
  article-title: Glycoengineering: The effect of glycosylation on the properties of therapeutic proteins
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.20319
– volume: 81
  start-page: 260
  year: 2015
  ident: ref_27
  article-title: Inactivation of a GAL4-like transcription factor improves cell fitness and product yield in glycoengineered Pichia pastoris strains
  publication-title: Appl. Environ. Microbiol.
  doi: 10.1128/AEM.02619-14
– volume: 116
  start-page: 281
  year: 1992
  ident: ref_30
  article-title: High-level secretion of the four salivary plasminogen activators from the vampire bat Desmodus rotundus by stably transfected baby hamster kidney cells
  publication-title: Gene
  doi: 10.1016/0378-1119(92)90526-U
– volume: 509
  start-page: 119
  year: 2014
  ident: ref_4
  article-title: Agonist-bound structure of the human P2Y12 receptor
  publication-title: Nature
  doi: 10.1038/nature13288
– volume: 104
  start-page: 960
  year: 2019
  ident: ref_41
  article-title: TREK-1 and TRAAK Are Principal K+ Channels at the Nodes of Ranvier for Rapid Action Potential Conduction on Mammalian Myelinated Afferent Nerves
  publication-title: Neuron
  doi: 10.1016/j.neuron.2019.08.042
– volume: 19
  start-page: 1473
  year: 2007
  ident: ref_62
  article-title: CYP703 is an ancient cytochrome P450 in land plants catalyzing in-chain hydroxylation of lauric acid to provide building blocks for sporopollenin synthesis in pollen
  publication-title: Plant Cell
  doi: 10.1105/tpc.106.045948
– volume: 76
  start-page: 2560
  year: 1990
  ident: ref_16
  article-title: Vampire bat salivary plasminogen activator is quiescent in human plasma in the absence of fibrin unlike human tissue plasminogen activator
  publication-title: Blood
  doi: 10.1182/blood.V76.12.2560.2560
– volume: 70
  start-page: 4219
  year: 2005
  ident: ref_24
  article-title: Protein glycosylation: New challenges and opportunities
  publication-title: J. Org. Chem.
  doi: 10.1021/jo050278f
– ident: ref_26
  doi: 10.1186/s12915-015-0136-2
– volume: 364
  start-page: 83
  year: 1999
  ident: ref_28
  article-title: Role of glycosylation in the functional expression of an Aspergillus niger phytase (phyA) in Pichia pastoris
  publication-title: Arch. Biochem. Biophys.
  doi: 10.1006/abbi.1999.1115
– volume: 6
  start-page: 567
  year: 2004
  ident: ref_8
  article-title: Technology evaluation: Desmoteplase, PAION/Forest
  publication-title: Curr. Opin. Mol. Ther.
– volume: 39
  start-page: 644
  year: 2013
  ident: ref_55
  article-title: Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: A multicenter propensity score analysis
  publication-title: Intensiv. Care Med.
  doi: 10.1007/s00134-013-2822-2
– volume: 25
  start-page: 2195
  year: 2018
  ident: ref_47
  article-title: Enhanced breast cancer progression by mutant p53 is inhibited by the circular RNA circ-Ccnb1
  publication-title: Cell Death Differ.
  doi: 10.1038/s41418-018-0115-6
– volume: 157
  start-page: 4
  year: 2012
  ident: ref_64
  article-title: Impact of albumin on drug delivery—New applications on the horizon
  publication-title: J. Control. Release
  doi: 10.1016/j.jconrel.2011.09.069
– volume: 25
  start-page: 566
  year: 2009
  ident: ref_32
  article-title: Construction of Pichia pastoris strain expressing salivary plasminogen activator from vampire bat (Desmodus rotundus)
  publication-title: Sheng Wu Gong Cheng Xue Bao
– volume: 4
  start-page: 14
  year: 2006
  ident: ref_39
  article-title: Development of an in vitro model to study clot lysis activity of thrombolytic drugs
  publication-title: Thromb. J.
  doi: 10.1186/1477-9560-4-14
– volume: 110
  start-page: 915
  year: 2012
  ident: ref_7
  article-title: Elucidating nature’s solutions to heart, lung, and blood diseases and sleep disorders
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.111.255398
– volume: 28
  start-page: 3537
  year: 2007
  ident: ref_56
  article-title: A biomimetic peptide fluorosurfactant polymer for endothelialization of ePTFE with limited platelet adhesion
  publication-title: Biomaterials
  doi: 10.1016/j.biomaterials.2007.04.026
– volume: 36
  start-page: 13483
  year: 1997
  ident: ref_35
  article-title: Catalytic domain structure of vampire bat plasminogen activator: A molecular paradigm for proteolysis without activation cleavage
  publication-title: Biochemistry
  doi: 10.1021/bi971129x
– volume: 84
  start-page: 244
  year: 1991
  ident: ref_43
  article-title: Effective thrombolysis without marked plasminemia after bolus intravenous administration of vampire bat salivary plasminogen activator in rabbits
  publication-title: Circulation
  doi: 10.1161/01.CIR.84.1.244
– volume: 129
  start-page: 2013
  year: 2017
  ident: ref_53
  article-title: Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis
  publication-title: Blood
  doi: 10.1182/blood-2016-09-742999
– volume: 359
  start-page: 545
  year: 2018
  ident: ref_21
  article-title: Structure of the yeast oligosaccharyltransferase complex gives insight into eukaryotic N-glycosylation
  publication-title: Science
  doi: 10.1126/science.aar5140
– volume: 4
  start-page: 58
  year: 2009
  ident: ref_63
  article-title: Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2008.213
– volume: 264
  start-page: 17947
  year: 1989
  ident: ref_14
  article-title: Isolation, characterization, and cDNA cloning of a vampire bat salivary plasminogen activator
  publication-title: J. Biol. Chem.
  doi: 10.1016/S0021-9258(19)84664-1
– volume: 49
  start-page: 352
  year: 1913
  ident: ref_40
  article-title: Die kinetik der invert in wirkung
  publication-title: Biochem. Z
– volume: 9
  start-page: 91
  year: 1995
  ident: ref_9
  article-title: DSPA alpha—Properties of the plasminogen activators of the vampire bat Desmodus rotundus
  publication-title: Fibrinolysis
  doi: 10.1016/S0268-9499(08)80020-3
– volume: 134
  start-page: 970
  year: 2019
  ident: ref_59
  article-title: Venous stasis-induced fibrinolysis prevents thrombosis in mice: Role of α2-antiplasmin
  publication-title: Blood
  doi: 10.1182/blood.2019000049
– ident: ref_46
– volume: 39
  start-page: 75
  year: 1995
  ident: ref_31
  article-title: Production of vampire bat plasminogen activator DSPA α1 in CHO and insect cells
  publication-title: J. Biotechnol.
  doi: 10.1016/0168-1656(94)00146-4
– volume: 44
  start-page: 3930
  year: 2022
  ident: ref_29
  article-title: Different N-Glycosylation Sites Reduce the Activity of Recombinant DSPAα2
  publication-title: Curr. Issues Mol. Biol.
  doi: 10.3390/cimb44090270
– volume: 123
  start-page: 2094
  year: 2013
  ident: ref_45
  article-title: SLITRK6 mutations cause myopia and deafness in humans and mice
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI65853
– volume: 270
  start-page: 25596
  year: 1995
  ident: ref_12
  article-title: Structural features mediating fibrin selectivity of vampire bat plasminogen activators
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.270.43.25596
– volume: 12
  start-page: 212
  year: 1992
  ident: ref_19
  article-title: Vampire bat salivary plasminogen activator promotes rapid and sustained reperfusion without concomitant systemic plasminogen activation in a canine model of arterial thrombosis
  publication-title: Arter. Thromb. A J. Vasc. Biol.
– ident: ref_36
– volume: 7
  start-page: 243
  year: 2008
  ident: ref_17
  article-title: Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: Therapeutic strategies
  publication-title: CNS Neurol. Disord. Drug Targets
  doi: 10.2174/187152708784936608
– ident: ref_22
– volume: 123
  start-page: 1326
  year: 2011
  ident: ref_51
  article-title: platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.110.000885
– volume: 132
  start-page: 15359
  year: 2010
  ident: ref_61
  article-title: Context-dependent effects of asparagine glycosylation on Pin WW folding kinetics and thermodynamics
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja106896t
SSID ssj0000651684
Score 2.2514386
Snippet DSPAα1 is a potent rude thrombolytic protein with high medicative value. DSPAα1 has two natural N-glycan sites (N153Q-S154-S155, N398Q-K399-T400) that may lead...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 985
SubjectTerms Amino acids
Bleeding
Cloning
Coagulation
Comparative analysis
Coronaviruses
COVID-19
Development and progression
drug safety
Drug therapy
DSPAα1
E coli
Fibrin
fibrin selectivity
Genetic aspects
Glycan
Glycoproteins
Glycosylation
Health aspects
Immune response
Immunological tolerance
In vivo methods and tests
Mutagenesis
Mutants
Mutation
N-glycosylation sites
Pharmaceuticals
Physiological aspects
Physiological effects
Plasmids
plasminogen activator
Proteins
rat
Safety
Temperature tolerance
Testing
Thromboembolism
Thrombolysis
Thrombolytic drugs
Yeast
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiDcppQoIxClq_IjjHJeW0iJaIZZKvVmOH1CpSiqye9ifxR_hNzFjp6tEHLhwi-zZKJ6J7Zn1l-8j5I1kbfDOi8J5CAOskqEwCLChyiNhEec2_pV9di5PLsSny-pyIvWFmLBED5wcdwAZtDdVsK1vhGgcU9IrWrsqNEGWPH5CzmDPmxRTaQ2uqFQiId051PUH11fBw3oN5QzKJk_2oEjV__eCPNmR5mjJyfZz_IDcH_PGfJGe9yG547tH5G5Sktw8Jp8Pt3qCeR_yhU2iELnpXL40wcMlNB8tvyx-_6Kx9XQ15OfFx-uN7YdNAsTlZ2vUFB6ekIvjD98OT4pRKKGwFa9XhaE0GNeWypWy5bxWUlSmMg2rfSmsY423ThimYAwtdSxIHiBrcVB-KV9yuMdTstP1nX9Ock6dQwIYH6gRCtwONwsOWe_awJqWZeTtrev0TeLD0FBHoIv11MUZeY9-3dogi3VsgNjqMbb6X7HNyGuMikaeig6BMN_Nehj06fKrXuD5q8BzvYy8G41CD_GxZvyuAMaD1FYzy72ZJUwkO---Db4eJ_Kg48FzBXWpzMirbTf-EsFpne_X0aZuUB-9zMiz9K5sx80R6wpJaUbU7C2aOWbe0139iDTfUUWZsXr3f7jyBbnHID1LmKM9srP6ufYvIZ1atftx5vwBwu0cSw
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELZgKyQuiDdpCwoIxClq_EjinNC2tLSIrqoulXqzHD9KpSopze5hfxZ_hN_ETOINGyFxW9mT7HrGHs_Ys99HyPucVd5ZJxLrwAzgJX2iscCGSoeARZyb7ij7dJYfX4ivl9llOHBrQ1nl2id2jto2Bs_I97obwAwShPzT7c8EWaPwdjVQaNwnW-CCpZyQrf3D2dn5cMoCz9Bcir7inUN-v3dz7R34bUhrkD55Yy_qIPv_dcwbO9O4anJjGzp6TB6F-DGe9gZ_Qu65-il50DNKrp6RbwcDr2Dc-HhqenKIWNc2nmvv4CM0f56fTX__ol3ryaKNZ8mXm5Vp2lVfGBefLpFbuH1OLo4Ovx8cJ4EwITEZLxaJptRrW6XSpnnFeSFzkelMl6xwqTCWlc5YoZmEMVTUMp9zD9GLhTRMupTDO16QSd3U7hWJObUWgWCcp1pIbyp4mbeIfld5VlYsIh_WqlO3PS6GgnwCVaw2VRyRfdTrIINo1l1Dc3elwuJQkCU5ncGXuFKI0jKZO0kLm_nS5ylnNCLv0CoK8SpqLIi50su2VSfzczXFe1iB93sR-RiEfAP2MTr8vwDGgxBXI8ndkSQsKDPuXhtfhQXdqr_TLyJvh258EovUatcsO5miRJ70NCIv-7kyjJtjzSsEpxGRo1k0Usy4p77-0cF9d2zKjBXb__9dO-QhgwCsryraJZPF3dK9hoBpUb0Jq-IPrgsVXQ
  priority: 102
  providerName: ProQuest
Title Comparison of Activity and Safety of DSPAα1 and Its N-Glycosylation Mutants
URI https://www.ncbi.nlm.nih.gov/pubmed/37109514
https://www.proquest.com/docview/2806552826
https://www.proquest.com/docview/2807914610
https://pubmed.ncbi.nlm.nih.gov/PMC10145227
https://doaj.org/article/550ea5fcbe9449d286e817d5f9f60321
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6VVkhcEG8CZRUQiFMgsfNwDghtS0uL2FXVZaXeLCe2S6VV0m52JfZn8Uf4Tcw42dVG5cgtsseJPOPHjD35PoC3KSus0SYOtEEz4CppA0UJNpEwBFjEeemOskfj9GQaf7tILnZgzTbaKbD5Z2hHfFLT-ezDr5vVZ5zwnyjixJD94-zKGlyKMVIRyR3Ywz0pIy6DUefot2tyEqUibjPfbzXq7UkOuv_2Ar21Q_WzJ7e2o-MHcL_zI_1ha_iHsGOqR3C3ZZZcPYbvhxt-Qb-2_rBsSSJ8VWl_oqzBRyz-Mjkb_vkdudLTReOPg6-zVVk3qzZBzh8tiWO4eQLT46MfhydBR5wQlAnPFoGKIqt0EQodpgXnmUjjRCUqZ5kJ41Kz3JQ6VkxgH4pIM5tyi16MxnBMmJDjO57CblVX5jn4PNKaAGGMjVQsbFngy6wmFLzCsrxgHrxbq05et_gYEuMKUrHcVrEHB6TXjQyhWruCen4pu0kiMVoyKsGPmDyOc81EakSU6cTmNg05izx4Q1aRhFtRUWLMpVo2jTydnMsh3cfGdM_nwftOyNZon1J1_xlgfwjqqie535PEiVX2q9fGl-txKd1FdIJxaurB6001taRktcrUSyeT5cSXHnrwrB0rm35zyn1FJ9UD0RtFPcX0a6qrnw7227EqM5a9-B-qfAn3GLprbQ7SPuwu5kvzCt2rRTGAvYOj8dn5wB1PDNw8-gtFJCYL
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB5VqRBcEG8MBQyi4mTV3vXzgFD6IqFJVDWt1Nuy3kepVNmlToTyp5D4I_wmZmwnxELi1pu1O7bXM7MzO7vj-QDexyy3RpvQ0wbFgFbSepISbILUUMEizlW9lT2exIOz8Mt5dL4BP5f_wlBa5dIm1oZal4r2yHfqE8AIA4T40_V3j1Cj6HR1CaHRqMWRWfzAkK36ONxH-W4zdnhwujfwWlQBT0U8mXkyCKzUuZ9qP845T9I4jGQkM5YYP1SaZUbpULLUaJUHmtmYW3TxGmOV1PhcEUoEmvzNkMc-68Hm7sHk-GS1q4NjDOI0bDLsOc_8natLa9BPYBhFcM1rvq-GCPjXEax5wm6W5prbO3wA99v1qttvFOwhbJjiEdxpECwXj2G0t8IxdEvr9lUDRuHKQrtTaQ1eYvP-9Lj_-1dQtw5nlTvxPl8tVFktmkQ8dzwnLOPqCZzdCiufQq8oC_McXB5oTYVnjA1kmFqV48Ospmp7uWVZzhzYXrJOXDd1OATGL8Risc5iB3aJrysaqp5dN5Q3F6KdjAKjMiMjfInJwjDTLI1NGiQ6spmNfc4CB96RVATVxygoAedCzqtKDKcnok_nviGdJzrwoSWyJcpHyfZ_BvweKqnVodzqUOIEVt3upfBFa0Aq8VfdHXi76qY7KSmuMOW8pkkywmX3HXjW6Mrquznl2OJi2IG0o0UdxnR7istvdXnxGr2ZseTF_8f1Bu4OTscjMRpOjl7CPYaLvyajaQt6s5u5eYWLtVn-up0hLny97Un5B4n4Up4
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEB5VqUBcEG8MBQyi4mTV3vXzgFDaNDS0jaKGSr1t1_solSq71IlQfhZXfgS_iRnbCbGQuPUW7Y4de547u-P5AN7HLLdGm9DTBsWAXtJ6kgpsgtRQwyLOVb2VfTyOD07DL2fR2Qb8Wn4LQ2WVS59YO2pdKtoj36lPACNMEOId25ZFTAbDT9ffPUKQopPWJZxGoyKHZvED07fq42iAst5mbLj_de_AaxEGPBXxZObJILBS536q_TjnPEnjMJKRzFhi_FBplhmlQ8lSo1UeaGZjbjHca8xbUuNzRYgR6P43E8qKerC5uz-enKx2ePB5gzgNm2p7zjN_5-rSGowZmFIRdPNaHKzhAv4NCmtRsVuxuRYChw_gfrt2dfuNsj2EDVM8gjsNmuXiMRztrTAN3dK6fdUAU7iy0O5UWoM_cXgwnfR__wzq0dGscsfe56uFKqtFU5TnHs8J17h6Aqe3wsqn0CvKwjwHlwdaUxMaYwMZplbleDOrqfNeblmWMwe2l6wT101PDoG5DLFYrLPYgV3i64qGOmnXA-XNhWgNU2CGZmSEf2KyMMw0S2OTBomObGZjn7PAgXckFUG9MgrSugs5ryoxmp6IPp0Bh3S26MCHlsiWKB8l228b8H2ovVaHcqtDicasutNL4YvWmVTir-o78HY1TVdSgVxhynlNk2SE0e478KzRldV7c6q3xYWxA2lHizqM6c4Ul9_qVuM1kjNjyYv_P9cbuIvGKI5G48OXcI_hOrApbtqC3uxmbl7hum2Wv24NxIXz27bJP0CvVtM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comparison+of+Activity+and+Safety+of+DSPA%CE%B11+and+Its+N-Glycosylation+Mutants&rft.jtitle=Life+%28Basel%2C+Switzerland%29&rft.au=Huakang+Peng&rft.au=Nan+Wang&rft.au=Mengqi+Wang&rft.au=Caifeng+Yang&rft.date=2023-04-01&rft.pub=MDPI+AG&rft.eissn=2075-1729&rft.volume=13&rft.issue=4&rft.spage=985&rft_id=info:doi/10.3390%2Flife13040985&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_550ea5fcbe9449d286e817d5f9f60321
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2075-1729&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2075-1729&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2075-1729&client=summon